Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

PROTHENA CORP PUBLIC LTD CO Director's Dealing 2015

Aug 14, 2015

32782_dirs_2015-08-14_e29dffee-eeb2-4402-b384-2e1aeb00f8f1.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Prothena Corp plc (PRTA)
CIK: 0001559053
Period of Report: 2015-08-12

Reporting Person: Walker Karin L (See Remarks)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2015-08-12 Ordinary Shares, par value $0.01 per share M 5000 $9.75 Acquired 5000 Direct
2015-08-12 Ordinary Shares, par value $0.01 per share S 2500 $61.6544 Disposed 2500 Direct
2015-08-12 Ordinary Shares, par value $0.01 per share S 2176 $62.4285 Disposed 324 Direct
2015-08-12 Ordinary Shares, par value $0.01 per share S 324 $63.2724 Disposed 0 Direct
2015-08-12 Ordinary Shares, par value $0.01 per share M 2000 $29.81 Acquired 2000 Direct
2015-08-12 Ordinary Shares, par value $0.01 per share S 900 $61.5094 Disposed 1100 Direct
2015-08-12 Ordinary Shares, par value $0.01 per share S 1100 $62.3341 Disposed 0 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2015-08-12 Stock Option (right to buy) $9.75 M 5000 Disposed 2023-06-02 Ordinary Shares (5000) Direct
2015-08-12 Stock Option (right to buy) $29.81 M 2000 Disposed 2024-02-04 Ordinary Shares (2000) Direct

Footnotes

F1: The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person.

F2: The transaction was executed in multiple trades in prices ranging from $61.05 to $62.05, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

F3: The transaction was executed in multiple trades in prices ranging from $62.16 to $63.04, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

F4: The transaction was executed in multiple trades in prices ranging from $63.14 to $63.33, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

F5: The transaction was executed in multiple trades in prices ranging from $61.06 to $61.93, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

F6: The transaction was executed in multiple trades in prices ranging from $62.19 to $62.53, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected.

F7: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on May 20, 2014 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.

F8: The shares subject to the option will vest and become exercisable as to 25% of the total number of shares subject to the option on February 4, 2015 and with respect to 1/48th of the total number of shares subject to the option in successive, equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.